.After antibody-drug conjugate (ADC) professional Seagen was actually sold to Pfizer in 2015 for an ...
.On the heels of a phase 3 win that fell short to wow investors, Ironwood Pharmaceuticals is back al...
.Don't quit Monte Rosa Therapeutics now. The Boston-based biotech is enjoying after authorizing a de...
.Welcome to today's Chutes & Ladders, our summary of considerable management hirings, firings and...
.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...
.AbbVie has come back to the resource of its antipsychotic giant Vraylar looking for yet another hit...
.GenSight Biologics is full weeks out of lacking money. Once more. The biotech only possesses adequa...
.Monopar Rehabs is recuperating a medication coming from the scrap heap of AstraZeneca's rare illnes...
.Along with brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one group of ...
.After developing a genetics treatment collaboration with Dyno Rehabs in 2020, Roche is back for eve...